NO20005352L - ascorbate - Google Patents
ascorbateInfo
- Publication number
- NO20005352L NO20005352L NO20005352A NO20005352A NO20005352L NO 20005352 L NO20005352 L NO 20005352L NO 20005352 A NO20005352 A NO 20005352A NO 20005352 A NO20005352 A NO 20005352A NO 20005352 L NO20005352 L NO 20005352L
- Authority
- NO
- Norway
- Prior art keywords
- ascorbate
- useful
- treatment
- cns disorders
- certain cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Paroksetinaskorbat er nyttig ved behandling av visse CNS-lidelser.Paroxetine ascorbate is useful in the treatment of certain CNS disorders.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005352L true NO20005352L (en) | 2000-10-24 |
| NO20005352D0 NO20005352D0 (en) | 2000-10-24 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005352A NO20005352D0 (en) | 1998-04-25 | 2000-10-24 | ascorbate |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (en) |
| JP (1) | JP2002513019A (en) |
| KR (1) | KR20010042977A (en) |
| CN (1) | CN1297448A (en) |
| AP (1) | AP2000001963A0 (en) |
| AU (1) | AU3618499A (en) |
| BG (1) | BG104940A (en) |
| BR (1) | BR9909868A (en) |
| CA (1) | CA2330055A1 (en) |
| EA (1) | EA200001104A1 (en) |
| GB (1) | GB9808896D0 (en) |
| HU (1) | HUP0102116A3 (en) |
| ID (2) | ID26654A (en) |
| IL (1) | IL139081A0 (en) |
| NO (1) | NO20005352D0 (en) |
| PL (1) | PL343677A1 (en) |
| SK (1) | SK15912000A3 (en) |
| TR (1) | TR200003084T2 (en) |
| WO (1) | WO1999055698A1 (en) |
| ZA (1) | ZA200005912B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| ES2412306T3 (en) | 2002-01-09 | 2013-07-11 | Emisphere Technologies, Inc. | Sodium 4 - ((4-Chloro-2-hydroxybenzoyl) amino) butanoate polymorphs |
| CN110607554B (en) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | Method for preparing medicine or medicine intermediate monocrystal or amorphous substance |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3688827T2 (en) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidine derivative, its manufacture and its use as a medicine. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (en) * | 1996-02-29 | 1999-07-01 | Ferrer Int | NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 ID IDW20002169A patent/ID26654A/en unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/en active Pending
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/en unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/en unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/en unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/en unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/en active Pending
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/en not_active Application Discontinuation
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/en not_active Application Discontinuation
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/en unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 PL PL99343677A patent/PL343677A1/en not_active Application Discontinuation
- 1999-04-23 EA EA200001104A patent/EA200001104A1/en unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/en not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999055698A1 (en) | 1999-11-04 |
| AU3618499A (en) | 1999-11-16 |
| HUP0102116A3 (en) | 2002-12-28 |
| IL139081A0 (en) | 2001-11-25 |
| JP2002513019A (en) | 2002-05-08 |
| BG104940A (en) | 2001-09-28 |
| EA200001104A1 (en) | 2001-04-23 |
| ID26083A (en) | 2000-11-23 |
| SK15912000A3 (en) | 2001-04-09 |
| ZA200005912B (en) | 2001-12-19 |
| HUP0102116A2 (en) | 2002-05-29 |
| EP1089995A1 (en) | 2001-04-11 |
| CN1297448A (en) | 2001-05-30 |
| PL343677A1 (en) | 2001-08-27 |
| NO20005352D0 (en) | 2000-10-24 |
| GB9808896D0 (en) | 1998-06-24 |
| TR200003084T2 (en) | 2001-02-21 |
| CA2330055A1 (en) | 1999-11-04 |
| BR9909868A (en) | 2000-12-19 |
| ID26654A (en) | 2001-01-25 |
| KR20010042977A (en) | 2001-05-25 |
| AP2000001963A0 (en) | 2000-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993051L (en) | Intranasal formulations for the treatment of sexual disorders | |
| NO991381L (en) | Combination therapy for the treatment of psychoses | |
| NO975747D0 (en) | Peptidyl heterocycles for use in the treatment of thrombin-related deficiencies | |
| NO20005884D0 (en) | Combination therapy for the treatment of bipolar disorders | |
| PT889886E (en) | NEW FENANTRIDINES REPLACED IN POSITION 6 | |
| NO20005032D0 (en) | Treatment of parasitic diseases by inhibition of cysteine proteases by the papain superfamily | |
| NO20005885D0 (en) | Combination therapy for the treatment of refractory depression | |
| EE200000093A (en) | Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis | |
| NO20014617D0 (en) | 1-Arensulfonyl-2-aryl pyrrolidine and piperidine derivatives for the treatment of CNS diseases | |
| YU48698A (en) | Carboxamide derivatives of pyrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorder | |
| ID27214A (en) | TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS | |
| CY1107039T1 (en) | TRIPEPTIDYL PEPTIDASE Suspensions | |
| NO20005352L (en) | ascorbate | |
| BR0012921A (en) | Calcally Compounds | |
| NO20003211D0 (en) | Triazine compounds for the treatment of CNS disorders | |
| NO984432L (en) | Procedure for the treatment of migraine pain | |
| SG148840A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| NO20011892D0 (en) | 3-tetrahydropyridin-4-yl indoles for the treatment of psychotic disorders | |
| NO990450D0 (en) | Treatment of mental disorders | |
| DK1133296T3 (en) | New therapeutic use of nicergoline | |
| NO20010390D0 (en) | Treatment of anxiety disorders | |
| NO20010569D0 (en) | Protease inhibitors for use in the treatment of psoriasis | |
| NO992021D0 (en) | Procedure for pulp treatment of wood pulp | |
| EE200200670A (en) | S-methyldihydroziprasidone for the treatment of psychiatric and ocular disorders | |
| NO962221D0 (en) | Use of dimeticone for the treatment of constipation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |